JonasPaludoMD
Hematology • Rochester, MNHematologic Oncology
Assistant Professor of Medicine and Oncology
Dr. Paludo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2018 - 2019- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2015 - 2019
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2012 - 2015
University of Miami/Jackson Health SystemInternship, Surgery, 2011 - 2012
Hlth Scis Fed Univ Porto AlegreClass of 2009, MD
Certifications & Licensure
MN State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 32 citationsChemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patientsJesus Vera Aguilera, Jonas Paludo, Robert R. McWilliams, Henan Zhang, Ying Li
Melanoma Research. 2020-08-01 - 213 citationsRepresentation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 YearsNarjust Duma, Jesus Vera Aguilera, Jonas Paludo, Candace L. Haddox, Miguel Gonzalez Velez
Journal of Oncology Practice. 2018-01-01 - 2 citationsMolecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.Melissa A Hopper, Kerstin Wenzl, Keenan T Hartert, Jordan E Krull, Abigail R Dropik
Hematological Oncology. 2023-10-01
Abstracts/Posters
- Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of LifeJonas Paludo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Early Fever Detection By a Novel Wearable Continuous Temperature Monitor in Patients Undergoing Autologous Stem Cell TransplantationJonas Paludo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for LymphomaJonas Paludo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Long Non-Coding RNA Expression in Waldenstrom Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Ibrutinib for the Treatment of Bing-Neel Syndrome2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Predictors of Short-Term Survival in Waldenström MacroglobulinemiaJuly 14th, 2020
Other Languages
- Portuguese
External Links
- Mayo Clinic Profilehttps://www.mayoclinic.org/biographies/paludo-jonas-m-d/bio-20456744
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
